Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
-
最新报道：Biotech firm 180 Life Sciences, whose stock has plummeted 99% from its peak, is pivoting to crypto by launching a new Ethereum-based token. The company, once valued at $500 million, announced plans to tokenize its intellectual property and research data on the blockchain. CEO Dr. James Woody stated the move aims to "democratize access to biotech investments" through decentralized finance. The firm will airdrop tokens to existing shareholders and use proceeds to fund ongoing clinical trials. This marks one of the first major biotech companies transitioning into Web3, though skeptics question the timing amid the firm's financial struggles.
下一篇
Hyperliquid Brief Outage Leaves Traders Unaffected
- Hyperliquid API downtime sees no major HYPE token impact; Standard Chartered's ETH forecas...
24小时热点
热点专题
412668